Arrowhead Pharmaceuticals Inc (NAS:ARWR)
$ 82.98 +3.175 (+3.98%) Market Cap: 11.69 Bil Enterprise Value: 10.88 Bil PE Ratio: 0 PB Ratio: 18.99 GF Score: 49/100

Arrowhead Pharmaceuticals Inc at TD Cowen Healthcare Conference Transcript

Mar 2, 2026 / 04:50 PM GMT
Release Date Price: $64.33 (+1.68%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

ARWR.OQ - Arrowhead Pharmaceuticals Inc
Arrowhead Pharmaceuticals Inc at TD Cowen Healthcare Conference
Mar 02, 2026 / 04:50PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
We'll go ahead and get started here today.

Thank you all for joining us in the room and online, for TD Cowan's forty-sixth annual, healthcare conference. I'm Joeho I'm one of the senior biotech analysts here on the team at TD Cowan, and it is my pleasure to have with us today the team from Arrowhead Pharmaceuticals. We have CEO Chris Anzaloneni and, CMO and head of RD James Hamilton. So thanks guys for joining us. Maybe, before we dive into the specific programs. Obviously a lot has happened, at the company over the past even 9 months in particular. So maybe if you want to just level set what are kind of the highlights and what should we be looking out for for the rest of 2026 and then we can
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot